Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy with Very Low Dose Elective Nodal IMRT for Head & Neck Cancer
NCT01372111Phase 2Unknown
- Sponsor
- Coastal Carolina Radiation Oncology
- Start
- Mar 2011
- Primary completion
- Mar 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in head and neck squamous cell carcinoma (HNSCC), sponsored by Coastal Carolina Radiation Oncology. Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01372111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01372111.